• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Synopsys Posts Financial Results for First Quarter Fiscal Year 2025

    2/26/25 4:05:00 PM ET
    $SNPS
    Computer Software: Prepackaged Software
    Technology
    Get the next $SNPS alert in real time by email

    Results Summary

    • Quarterly revenue of $1.455 billion, exceeding midpoint of guidance.
    • Quarterly GAAP earnings per diluted share of $1.89; non-GAAP earnings per diluted share of $3.03, exceeding guidance.
    • Reaffirming full-year 2025 guidance.

    SUNNYVALE, Calif., Feb. 26, 2025 /PRNewswire/ -- Synopsys, Inc. (Nasdaq: SNPS) today reported results for its first quarter of fiscal year 2025. Revenue for the first quarter of fiscal year 2025 was $1.455 billion, compared to $1.511 billion for the first quarter of fiscal year 2024.

    Synopsys headquarters in Sunnyvale, Calif. (PRNewsfoto/Synopsys, Inc.)

    "In Q1, Synopsys' relentless focus on execution and innovation was evident across the business. We launched industry-leading silicon IP and hardware-assisted verification solutions while expanding generative AI capabilities in EDA," said Sassine Ghazi, president and CEO of Synopsys. "We are continuing to see strong design activity at advanced nodes, fueled by the AI-driven reinvention of compute. As the pace and complexity of technology innovation increases, new silicon-to-systems design paradigms are essential, and Synopsys is well-positioned to deliver."

    "We delivered a solid start to the year, with non-GAAP earnings above guidance, and revenue in the upper end of our guided range," said Shelagh Glaser, CFO of Synopsys. "These results are a product of our resilient business model, strong operational execution, and leading technology that is mission-critical to customers. We are reaffirming our full-year guidance including expectations for double-digit revenue growth."

    Continuing Operations 

    On September 30, 2024, Synopsys completed the sale of its Software Integrity business. Unless otherwise noted, Synopsys' Software Integrity business has been presented as a discontinued operation in the Synopsys' consolidated financial statements for all periods presented herein and all financial results and targets are presented herein on a continuing operations basis.

    GAAP Results

    On a U.S. generally accepted accounting principles (GAAP) basis, net income for the first quarter of fiscal year 2025 was $295.7 million, or $1.89 per diluted share, compared to $437.5 million, or $2.82 per diluted share, for the first quarter of fiscal year 2024.

    Non-GAAP Results

    On a non-GAAP basis, net income for the first quarter of fiscal year 2025 was $473.2 million, or $3.03 per diluted share, compared to non-GAAP net income of $525.5 million, or $3.38 per diluted share, for the first quarter of fiscal year 2024.

    For a reconciliation of net income, earnings per diluted share and other measures on a GAAP and non-GAAP basis, see "GAAP to Non-GAAP Reconciliation" in the accompanying tables below.

    Business Segments 

    Synopsys reports revenue and operating income in two segments: (1) Design Automation, which includes our advanced silicon design, verification products and services, system integration products and services, digital, custom and field programmable gate array IC design software, verification software and hardware products, manufacturing software products and other and (2) Design IP, which includes our interface, foundation, security, and embedded processor IP, IP subsystems, and IP implementation services.

    Financial Targets 

    Synopsys also provided its consolidated financial targets for the second quarter and full fiscal year 2025. These targets reflect a change in Synopsys' fiscal year from a 52/53-week period ending on the Saturday nearest to October 31 of each year to October 31 of each year. As a result of this change, there will be ten fewer days in the first half of fiscal year 2025 and two extra days in the second half of fiscal year 2025, which results in eight fewer days in the aggregate in Synopsys' fiscal year 2025 as compared to its fiscal year 2024. These targets also assume no further changes to export control restrictions or the current U.S. government "Entity List" restrictions. These targets constitute forward-looking statements and are based on current expectations. For a discussion of factors that could cause actual results to differ materially from these targets, see "Forward-Looking Statements" below. 

    Second Quarter and Full Fiscal Year 2025 Financial Targets (1)

    (in millions except per share amounts)















     Range for Three Months Ending



    Range for Fiscal Year Ending



    April 30, 2025



    October 31, 2025



    Low

    High



    Low

    High

    Revenue

    $              1,585

    $              1,615



    $              6,745

    $              6,805

    GAAP Expenses

    $              1,191

    $              1,211



    $              4,972

    $              5,029

    Non-GAAP Expenses

    $                 985

    $                 995



    $              4,045

    $              4,085

    Non-GAAP Interest and Other Income (Expense), net

    $                   24

    $                   26



    $                   94

    $                   98

    Non-GAAP Tax Rate

    16 %

    16 %



    16 %

    16 %

    Outstanding Shares (fully diluted)

    156

    158



    157

    159

    GAAP EPS

    $                2.21

    $                2.33



    $              10.09

    $              10.31

    Non-GAAP EPS

    $                3.37

    $                3.42



    $              14.88

    $              14.96

    Operating Cash Flow







    ~$1,800

    Free Cash Flow(2)







    ~$1,600

    Capital Expenditures







    ~$170













    (1) Targets do not reflect the impact of any future financing transactions related to the Ansys Merger (as defined below) or targets for the combined company.

    (2) Free cash flow is calculated as cash provided from operating activities less capital expenditures.

    For a reconciliation of Synopsys' second quarter and fiscal year 2025 targets, including expenses, earnings per diluted share and other measures on a GAAP and non-GAAP basis and a discussion of the financial targets that we are not able to reconcile without unreasonable efforts, see "GAAP to Non-GAAP Reconciliation" in the accompanying tables below.

    Earnings Call Open to Investors

    Synopsys will hold a conference call for financial analysts and investors today at 2:00 p.m. Pacific Time. A live webcast of the call will be available on Synopsys' corporate website at investor.synopsys.com. Synopsys uses its website as a tool to disclose important information about Synopsys and comply with its disclosure obligations under Regulation Fair Disclosure. A webcast replay will also be available on the corporate website from approximately 5:30 p.m. Pacific Time today through the time Synopsys announces its results for the second quarter of fiscal year 2025 in May 2025.

    Effectiveness of Information

    The targets included in this press release, the statements made during the earnings conference call, the information contained in the financial supplement and the corporate overview presentation, each of which are available on Synopsys' corporate website at www.synopsys.com (collectively, the "Earnings Materials"), represent Synopsys' expectations and beliefs as of February 26, 2025. Although these Earnings Materials will remain available on Synopsys' website through the date of the earnings call for the second quarter of fiscal year 2025, their continued availability through such date does not mean that Synopsys is reaffirming or confirming their continued validity. Synopsys undertakes no duty and does not intend to update any forward-looking statement, whether as a result of new information or future events, or otherwise update, the targets given in this press release unless required by law.

    Availability of Final Financial Statements

    Synopsys will include final financial statements for the first quarter of fiscal year 2025 in its quarterly report on Form 10-Q to be filed on or before March 12, 2025.

    About Synopsys

    Catalyzing the era of pervasive intelligence, Synopsys, Inc. (NASDAQ:SNPS) delivers trusted and comprehensive silicon to systems design solutions, from electronic design automation to silicon IP and system verification and validation. We partner closely with semiconductor and systems customers across a wide range of industries to maximize their R&D capability and productivity, powering innovation today that ignites the ingenuity of tomorrow. Learn more at www.synopsys.com.

    Reconciliation of First Quarter Fiscal Year 2025 Results

    The following tables reconcile the specific items excluded from GAAP in the calculation of non-GAAP net income, earnings per diluted share, and tax rate for the periods indicated below.

    GAAP to Non-GAAP Reconciliation of First Quarter Fiscal Year 2025 Results(1)

    (unaudited and in thousands, except per share amounts)











    Three Months Ended



    January 31,



    2025



    2024

    GAAP net income from continuing operations attributed to Synopsys

    $               295,683



    $       437,450

    Adjustments:







    Amortization of acquired intangible assets

    12,596



    15,601

    Stock-based compensation

    186,279



    165,141

    Acquisition/divestiture related items

    74,829



    31,932

    Gain on sale of strategic investments

    —



    (55,077)

    Tax adjustments

    (96,214)



    (69,567)

    Non-GAAP net income from continuing operations attributed to Synopsys

    $               473,173



    $       525,480



























    Three Months Ended



    January 31,



    2025



    2024

    GAAP net income from continuing operations per diluted share attributed to Synopsys

    $                      1.89



    $              2.82

    Adjustments:







    Amortization of acquired intangible assets

    0.08



    0.10

    Stock-based compensation

    1.19



    1.06

    Acquisition/divestiture related items

    0.48



    0.21

    Gain on sale of strategic investments

    —



    (0.35)

    Tax adjustments

    (0.61)



    (0.46)

    Non-GAAP net income from continuing operations per diluted share attributed to Synopsys

    $                      3.03



    $              3.38

















    Shares used in computing net income per diluted share amounts:

    156,189



    155,334









    (1) Synopsys' first quarter of fiscal year 2025 and 2024 ended on January 31, 2025 and February 3, 2024, respectively. For presentation purposes,

    we refer to the closest calendar month end. Fiscal year 2024 was a 53-week year, which included an extra week in the first quarter.

     

    GAAP to Non-GAAP Tax Rate Reconciliation

    (unaudited)







    Three Months Ended



    January 31, 2025





    GAAP effective tax rate

    (2.2) %

    Stock-based compensation

    4.3 %

    Acquisition/divestiture related items (1)

    12.6 %

    Tax adjustments (2)

    1.3 %

    Non-GAAP effective tax rate

    16.0 %





    (1) The adjustment is primarily due to the capital loss on the sale of Synopsys'

    ownership in OpenLight Photonics, Inc.

    (2) The adjustments are primarily related to the differences in the tax rate effect of

    certain deductions, such as the deduction for foreign-derived intangible income and

    credits.

    Reconciliation of 2025 Targets

    The following tables reconcile the specific items excluded from GAAP in the calculation of non-GAAP targets for the periods indicated below.

    GAAP to Non-GAAP Reconciliation of Second Quarter Fiscal Year 2025 Targets

    (in thousands, except per share amounts)





















     Range for Three Months Ending





    April 30, 2025





    Low



    High

    Target GAAP expenses



    $          1,191,000



    $          1,211,000

    Adjustments:









          Amortization of acquired intangible assets



    (12,000)



    (15,000)

          Stock-based compensation



    (194,000)



    (201,000)

    Target non-GAAP expenses



    $              985,000



    $              995,000































    Range for Three Months Ending





    April 30, 2025





    Low



    High

    Target GAAP earnings per diluted share attributed to Synopsys



    $                    2.21



    $                    2.33

    Adjustments:









          Amortization of acquired intangible assets



    0.10



    0.08

          Stock-based compensation



    1.28



    1.24

          Acquisition/divestiture related items (1)



    0.08



    0.06

          Tax adjustments



    (0.30)



    (0.29)

    Target non-GAAP earnings per diluted share attributed to Synopsys



    $                    3.37



    $                    3.42











    Shares used in non-GAAP calculation (midpoint of target range)



    157,000



    157,000

     

    GAAP to Non-GAAP Reconciliation of Full Fiscal Year 2025 Targets

    (in thousands, except per share amounts)





















    Range for Fiscal Year Ending





    October 31, 2025





    Low



    High

    Target GAAP expenses



    $          4,971,681



    $          5,028,681

    Adjustments:









          Amortization of acquired intangible assets



    (46,000)



    (51,000)

          Stock-based compensation



    (820,000)



    (832,000)

          Acquisition/divestiture related items (1)



    (60,681)



    (60,681)

    Target non-GAAP expenses



    $          4,045,000



    $          4,085,000































    Range for Fiscal Year Ending





    October 31, 2025





    Low



    High

    Target GAAP earnings per diluted share attributed to Synopsys



    $                  10.09



    $                  10.31

    Adjustments:









          Amortization of acquired intangible assets



    0.32



    0.29

          Stock-based compensation



    5.27



    5.19

          Acquisition/divestiture related items (1)



    0.70



    0.66

          Tax adjustments



    (1.50)



    (1.49)

    Target non-GAAP earnings per diluted share attributed to Synopsys



    $                  14.88



    $                  14.96











    Shares used in non-GAAP calculation (midpoint of target range)



    158,000



    158,000











    (1)  Adjustments reflect actual expenses incurred by Synopsys as of January 31, 2025 or certain contractually

    obligated financing fees and related amortization expenses, and do not fully reflect all potential adjustments

    for future periods for the reasons set forth in "GAAP to Non-GAAP Reconciliation" below.

    Forward-Looking Statements

    This press release and the investor conference call contain forward-looking statements, including, but not limited to, statements regarding short-term and long-term financial targets, expectations and objectives including, among others, our long-term financial objectives, which include the anticipated effects of our pending acquisition of ANSYS, Inc. (the Ansys Merger); our products, technology and services; business and market outlook, opportunities, strategies and technological trends, such as artificial intelligence (AI); planned acquisitions and their expected impact, such as the Ansys Merger; planned dispositions and their expected impact; the potential impact of the uncertain macroeconomic environment on our financial results, including, but not limited to, the effects of sustained global inflationary pressures and elevated interest rates, potential economic slowdowns or recessions, supply chain disruptions, geopolitical pressures, including, among others, the unknown impact of current and future U.S. and foreign trade regulations, government actions and regulatory changes, such as export control restrictions and tariffs, and regional or global military conflicts, and fluctuations in foreign exchange rates, and associated global economic conditions; customer demand and market expansion; our planned product releases and capabilities; industry growth rates; the expected realization of our contracted but unsatisfied or partially unsatisfied performance obligations (backlog); software trends; planned stock repurchases; our expected tax rate; and the impact and result of pending legal, regulatory, administrative and tax proceedings. These statements involve risks, uncertainties and other factors that could cause our actual results, time frames or achievements to differ materially from those expressed or implied in such forward-looking statements. Such risks, uncertainties and factors include, but are not limited to: macroeconomic conditions and geopolitical uncertainty in the global economy; uncertainty in the growth of the semiconductor and electronics industries; the highly competitive industry we operate in; actions by the U.S. or foreign governments, such as the imposition of additional export restrictions or tariffs; consolidation among our customers and our dependence on a relatively small number of large customers; risks and compliance obligations relating to the global nature of our operations; failure to complete the Ansys Merger on the terms described in our filings with the SEC, if at all; failure to obtain required governmental approvals related to the Ansys Merger or the imposition of conditions to such governmental approvals that may have an adverse effect on us; failure to realize the benefits expected from the Ansys Merger; and more. Additional information on potential risks, uncertainties and other factors that could affect Synopsys' results is included in filings we make with the SEC from time to time, including in the sections entitled "Risk Factors" in our latest Annual Report on Form 10-K and in our latest Quarterly Report on Form 10-Q. The financial information contained in this press release should be read in conjunction with the consolidated financial statements and notes thereto included in Synopsys' most recent reports on Forms 10-K and 10-Q, each as may be amended from time to time. Synopsys' financial results for its first quarter of fiscal year 2025 are not necessarily indicative of Synopsys' operating results for any future periods. The information provided herein is as of February 26, 2025. Synopsys undertakes no duty to, and does not intend to, update any forward-looking statement, whether as a result of new information, future events or otherwise, unless required by law.

    SYNOPSYS, INC.

    Unaudited Condensed Consolidated Statements of Income (1)

    (in thousands, except per share amounts)



















    Three Months Ended



    January 31,



    2025



    2024

    Revenue:







      Time-based products

    $                828,238



    $                805,063

      Upfront products

    368,124



    442,366

        Total products revenue

    1,196,362



    1,247,429

      Maintenance and service

    258,953



    263,560

          Total revenue

    1,455,315



    1,510,989

    Cost of revenue:







      Products

    168,842



    175,498

      Maintenance and service

    92,537



    90,540

      Amortization of acquired intangible assets

    8,596



    13,155

          Total cost of revenue

    269,975



    279,193

    Gross margin

    1,185,340



    1,231,796

    Operating expenses:







      Research and development

    553,216



    525,534

      Sales and marketing

    209,199



    218,843

      General and administrative

    167,086



    131,264

      Amortization of acquired intangible assets

    4,000



    3,529

          Total operating expenses

    933,501



    879,170

    Operating income

    251,839



    352,626

    Interest and other income (expense), net

    39,278



    104,828

    Income before income taxes

    291,117



    457,454

    Provision (benefit) for income taxes

    (6,294)



    22,909

    Net income from continuing operations

    297,411



    434,545

    Income from discontinued operations, net of income taxes

    —



    11,662

    Net income

    297,411



    446,207

    Less: Net income (loss) attributed to non-controlling interest and

    redeemable non-controlling interest

    1,728



    (2,905)

    Net income attributed to Synopsys

    $                295,683



    $                449,112









    Net income attributed to Synopsys







     Continuing operations

    $                295,683



    $                437,450

     Discontinued operations

    —



    11,662

     Net income

    $                295,683



    $                449,112









    Net income per share attributed to Synopsys - basic:







      Continuing operations

    $                      1.91



    $                      2.87

      Discontinued operations

    —



    0.08

      Basic net income per share

    $                      1.91



    $                      2.95









    Net income per share attributed to Synopsys - diluted:







      Continuing operations

    $                      1.89



    $                      2.82

      Discontinued operations

    —



    0.07

      Diluted net income per share

    $                      1.89



    $                      2.89









    Shares used in computing per share amounts:







      Basic

    154,408



    152,311

      Diluted

    156,189



    155,334









    (1) Synopsys' first quarter of fiscal year 2025 and 2024 ended on January 31, 2025 and February 3, 2024, respectively.

    For presentation purposes, we refer to the closest calendar month end. Fiscal year 2024 was a 53-week year, which

    included an extra week in the first quarter.

     

    SYNOPSYS, INC.



    Unaudited Condensed Consolidated Balance Sheets (1)



    (in thousands, except par value amounts)



















    January 31, 2025



    October 31, 2024



    ASSETS:











    Current assets:











      Cash and cash equivalents



    $             3,653,880



    $             3,896,532



      Short-term investments



    155,489



    153,869



              Total cash, cash equivalents and short-term investments



    3,809,369



    4,050,401



      Accounts receivable, net



    892,647



    934,470



      Inventories



    415,199



    361,849



      Prepaid and other current assets



    1,206,401



    1,122,946



              Total current assets



    6,323,616



    6,469,666



    Property and equipment, net



    546,406



    563,006



    Operating lease right-of-use assets, net



    545,867



    565,917



    Goodwill



    3,433,369



    3,448,850



    Intangible assets, net



    180,950



    195,164



    Deferred income taxes



    1,393,044



    1,247,258



    Other long-term assets



    617,837



    583,700



               Total assets



    $           13,041,089



    $           13,073,561















    LIABILITIES, REDEEMABLE NON-CONTROLLING INTEREST AND

    STOCKHOLDERS' EQUITY:











    Current liabilities:











      Accounts payable and accrued liabilities



    $                938,679



    $             1,163,592



      Operating lease liabilities



    99,310



    94,791



      Deferred revenue



    1,320,605



    1,391,737



               Total current liabilities



    2,358,594



    2,650,120



    Long-term operating lease liabilities



    551,507



    574,065



    Long-term deferred revenue



    316,178



    340,831



    Long-term debt



    14,220



    15,601



    Other long-term liabilities



    495,689



    469,738



               Total liabilities



    3,736,188



    4,050,355



    Redeemable non-controlling interest



    —



    30,000



    Stockholders' equity:











      Preferred stock, $0.01 par value: 2,000 shares authorized; none outstanding



    —



    —



      Common stock, $0.01 par value: 400,000 shares authorized; 154,618 and 154,112

    shares outstanding, respectively



    1,547



    1,541



      Capital in excess of par value



    1,127,181



    1,211,206



      Retained earnings



    9,278,950



    8,984,105



      Treasury stock, at cost: 2,643 and 3,148 shares, respectively



    (860,967)



    (1,025,770)



      Accumulated other comprehensive income (loss)



    (241,919)



    (180,380)



               Total Synopsys stockholders' equity



    9,304,792



    8,990,702



    Non-controlling interest



    109



    2,504



               Total stockholders' equity



    9,304,901



    8,993,206



               Total liabilities, redeemable non-controlling interest and stockholders' equity



    $           13,041,089



    $           13,073,561















    (1) Synopsys' first quarter of fiscal year 2025 ended on January 31, 2025 and its fiscal year 2024 ended on November 2, 2024,

    respectively. For presentation purposes, we refer to the closest calendar month end. Fiscal year 2024 was a 53-week year,

    which included an extra week in the first quarter.





     

    SYNOPSYS, INC.

    Unaudited Condensed Consolidated Statements of Cash Flows (1)

    (in thousands)











    Three Months Ended January 31,



    2025



    2024

    CASH FLOWS FROM OPERATING ACTIVITIES:







    Net income

    $                297,411



    $                446,207

    Adjustments to reconcile net income to net cash used in operating activities:







    Amortization and depreciation

    47,934



    62,888

    Reduction of operating lease right-of-use assets

    25,473



    24,376

    Amortization of capitalized costs to obtain revenue contracts

    12,466



    18,726

    Stock-based compensation

    186,463



    180,652

    Allowance for credit losses

    9,919



    6,059

    Gain on sale of strategic investments

    —



    (55,077)

    Amortization of bridge financing costs

    10,468



    1,000

    Deferred income taxes

    (139,075)



    (101,332)

    Other

    186



    (786)

    Net changes in operating assets and liabilities, net of effects from acquisitions and dispositions:







    Accounts receivable

    30,948



    (119,571)

    Inventories

    (55,852)



    (60,883)

    Prepaid and other current assets

    (103,567)



    (96,916)

    Other long-term assets

    (43,494)



    (72,096)

    Accounts payable and accrued liabilities

    (313,651)



    (266,704)

    Operating lease liabilities

    (23,102)



    (23,569)

    Income taxes

    86,992



    (117,798)

    Deferred revenue

    (96,974)



    87,034

    Net cash used in operating activities

    (67,455)



    (87,790)









    CASH FLOWS FROM INVESTING ACTIVITIES:







    Proceeds from maturities of short-term investments

    19,684



    24,559

    Proceeds from sales of short-term investments

    16,411



    —

    Purchases of short-term investments

    (37,269)



    (25,612)

    Proceeds from sales of strategic investments

    —



    55,696

    Purchases of strategic investments

    (3,288)



    (822)

    Purchases of property and equipment, net

    (40,715)



    (40,391)

    Acquisitions, net of cash acquired

    —



    (67,827)

    Proceeds from business divestiture, net of cash divested

    23,808



    —

    Other

    (611)



    —

    Net cash used in investing activities

    (21,980)



    (54,397)









    CASH FLOWS FROM FINANCING ACTIVITIES:







    Repayment of debt

    (1,289)



    (1,303)

    Payment of bridge financing and term loan costs

    —



    (48,000)

    Issuances of common stock

    14,417



    9,483

    Payments for taxes related to net share settlement of equity awards

    (124,966)



    (147,330)

    Redemption of redeemable non-controlling interest

    (30,000)



    —

    Net cash used in financing activities

    (141,838)



    (187,150)

    Effect of exchange rate changes on cash, cash equivalents and restricted cash

    (9,676)



    9,320

    Net change in cash, cash equivalents and restricted cash

    (240,949)



    (320,017)

    Cash, cash equivalents and restricted cash, beginning of year, including cash from discontinued operations

    3,898,729



    1,441,187

    Cash, cash equivalents and restricted cash, end of period, including cash from discontinued operations

    3,657,780



    1,121,170

    Less: Cash, cash equivalents and restricted cash from discontinued operations

    —



    4,962

    Cash, cash equivalents and restricted cash from continuing operations

    $             3,657,780



    $             1,116,208

















    (1) Synopsys' first quarter of fiscal year 2025 and 2024 ended on January 31, 2025 and February 3, 2024, respectively. For presentation purposes,

    we refer to the closest calendar month end. Fiscal year 2024 was a 53-week year, which included an extra week in the first quarter.

    Synopsys provides segment information, namely revenue, adjusted segment operating income and adjusted segment operating margin, in accordance with Financial Accounting Standards Board Accounting Standards Codification Topic 280, Segment Reporting. Synopsys' chief operating decision maker ("CODM") is our Chief Executive Officer. In evaluating our business segments, the CODM considers the income and expenses that the CODM believes are directly related to those segments. The CODM does not allocate certain operating expenses managed at a consolidated level to our business segments and, as a result, the reported operating income and operating margin do not include these unallocated expenses as shown in the table below. These unallocated expenses are presented in the table below to provide a reconciliation of the total adjusted operating income from segments to our consolidated operating income from continuing operations:

     

    SYNOPSYS, INC.

    Business Segment Reporting (1)(2)

    (in millions)











    Three Months Ended

    January 31, 2025



    Three Months Ended

    January 31, 2024





    Revenue by segment







    - Design Automation

    $                    1,020.2



    $                        985.3

    % of Total

    70.1 %



    65.2 %

    - Design IP

    $                       435.1



    $                        525.7

    % of Total

    29.9 %



    34.8 %









    Adjusted operating income by segment







    - Design Automation

    $                       404.7



    $                        359.5

    - Design IP

    $                       126.5



    $                        245.7









    Adjusted operating margin by segment







    - Design Automation

    39.7 %



    36.5 %

    - Design IP

    29.1 %



    46.7 %

     

    Total Adjusted Segment Operating Income Reconciliation (1)(2)

    (in millions)











    Three Months Ended

    January 31, 2025



    Three Months Ended

    January 31, 2024





    GAAP total operating income – as reported

    $                          251.8



    $                          352.6

    Other expenses managed at consolidated level







    -Amortization of acquired intangible assets

    12.6



    16.7

    -Stock-based compensation (3)

    186.5



    165.5

    -Non-qualified deferred compensation plan

    19.6



    39.4

    -Acquisition/divestiture related items (4)

    60.7



    30.9

    Total adjusted segment operating income

    $                          531.2



    $                          605.2









    (1) Synopsys manages the business on a long-term, annual basis, and considers quarterly fluctuations of

    revenue and profitability as normal elements of our business. Amounts may not foot due to rounding.

    (2) Synopsys' first quarter of fiscal year 2025 and 2024 ended on January 31, 2025 and February 3,

    2024, respectively. For presentation purposes, we refer to the closest calendar month end. Fiscal year

    2024 was a 53-week year, which included an extra week in the first quarter.

    (3) The adjustment includes non-GAAP expenses attributable to non-controlling interest and

    redeemable non-controlling interest.

    (4) The adjustment excludes the amortization of bridge financing costs entered into in connection with

    the pending Ansys Merger, and certain divestiture related items that were recorded in interest and other

    income (expense), net, in our unaudited condensed consolidated statements of income.

    GAAP to Non-GAAP Reconciliation

    Synopsys continues to provide all information required in accordance with GAAP but acknowledges evaluating its ongoing operating results may not be as useful if an investor is limited to reviewing only GAAP financial measures. Accordingly, Synopsys presents non-GAAP financial measures in reporting its financial results to provide investors with an additional tool to evaluate Synopsys' operating results in a manner that focuses on what Synopsys believes to be its core business operations and what Synopsys uses to evaluate its business operations and for internal budgeting and resource allocation purposes. This press release includes non-GAAP earnings per diluted share, non-GAAP net income and non-GAAP tax rate for the periods presented. It also includes future estimates for non-GAAP expenses, non-GAAP interest and other income (expense), non-GAAP tax rate, non-GAAP earnings per diluted share and free cash flow. These non-GAAP financial measures may be different from non-GAAP financial measures used by other companies.

    When possible, Synopsys provides a reconciliation of non-GAAP financial measures to their most closely applicable GAAP financial measures. Synopsys is unable to provide a full reconciliation of certain second quarter and full fiscal year 2025 non-GAAP financial targets to the corresponding GAAP financial measures on a forward-looking basis because Synopsys believes that it would not be possible for it to have the required information necessary to quantitatively reconcile such measures with sufficient precision without unreasonable efforts due to, among other things, the potential variability and limited predictability of the excluded adjustment items necessary for a full reconciliation such as certain acquisition/divestiture related items, restructuring charges, tax deduction variability, changes in the fair value of non-qualified deferred compensation plan, and gains (losses) on the sale of strategic investments. For the same reasons, Synopsys is unable to address the probable significance of the unavailable information. 

    Synopsys' management does not itself, nor does it suggest that investors should, consider such non-GAAP financial measures in isolation from, as superior to, or as a substitute for, financial information prepared in accordance with GAAP. These non-GAAP financial measures are meant to supplement, and be viewed in conjunction with, the corresponding GAAP financial measures. Synopsys' management believes presentation of non-GAAP financial measures, when shown in conjunction with the corresponding GAAP financial measures, provides useful information to investors allowing them to view financial and business trends relating to our financial condition and results of operations through the eyes of management. Synopsys' management evaluates and makes decisions about our business operations using both GAAP financial measures and non-GAAP financial measures to help facilitate internal comparisons to Synopsys' historical operating results and forecasted targets, planning and forecasting in subsequent periods and comparisons to competitors' operating results.

    The following are descriptions of the adjustments made to reconcile non-GAAP financial measures (other than free cash flow, which is defined in the footnote to the Financial Targets table above) to the most directly comparable GAAP financial measures:

    (i) Amortization of acquired intangible assets. We incur expenses from amortization of acquired intangible assets, which may include impairment charges from write-downs of acquired intangible assets. Acquired intangible assets include, among other things, core/developed technology, customer relationships, contract rights, trademarks and trade names, and other intangibles related to acquisitions. We amortize the intangible assets over their estimated useful lives. We do not enter into acquisitions on a predictable cycle. The amount of an acquisition's purchase price allocated to intangible assets and their estimated useful lives can vary significantly and are unique to each acquisition. From time to time, we incur impairment charges due to write-downs of acquired intangible assets. We believe that the presentation of non-GAAP financial measures that adjust for the amortization of intangible assets, including impairment charges, provides investors and others with a consistent basis for comparison across accounting periods. We also exclude this item because such expenses are non-cash in nature and we believe the non-GAAP financial measures excluding this item provide meaningful supplemental information regarding our core operational performance and liquidity, and ability to invest in research and development and fund future acquisitions and capital expenditures.

    (ii) Stock-based compensation. Stock-based compensation expenses consist primarily of expenses related to restricted stock units, stock options, employee stock purchase rights and other stock awards, including such expenses associated with acquisitions. We exclude stock-based compensation expense from our non-GAAP financial measures primarily because it is not an expense that typically requires or will require cash settlement by us. Further, the expense for the fair value of the stock-based instruments we utilize may bear little resemblance to the actual value realized upon the vesting or future exercise of the related stock-based awards and, therefore, is not used by management to assess the core profitability of our business operations.

    (iii) Acquisition/divestiture related items. In connection with certain of our business combinations and/or divestitures, we incur significant expenses that we would not have otherwise incurred as part of our business operations. These expenses include, among other things, compensation expenses, professional fees and other direct expenses, concurrent restructuring activities and divestiture activities, including employee severance and other exit costs, bridge financing costs, costs related to integration activities, debt forgiveness, changes to the fair value of contingent consideration related to the acquired company, and amortization of the fair value difference of below-market value assets arising from arrangements entered into or acquired in conjunction with an acquisition. We also recognize the gains and losses from the mark-up of equity or cost method investments to fair value upon obtaining control through acquisition. We exclude these items because they are related to acquisitions and divestitures and have no direct correlation to the core operation of our business. Further, because we do not acquire or divest businesses on a predictable cycle and the terms of each transaction can vary significantly and are unique to each transaction, we believe it is useful to exclude such expenses when looking for a consistent basis for comparison across accounting periods.

    (iv) Restructuring charges. We initiate restructuring activities to align our costs to our operating plans and business strategies based on then-current economic conditions, and such activities have a specific and defined term. Restructuring costs generally include severance and other termination benefits related to voluntary retirement programs, involuntary headcount reductions and facilities closures. Such restructuring costs include elimination of operational redundancy, permanent reductions in workforce and facilities closures and, therefore, are not considered by us to be a part of the core operation of our business and are not used by management when assessing the core profitability and performance of our business operations.

    (v) Gains (losses) on the sale of strategic investments. We exclude gains and losses on the sale of equity investments in privately held companies because we do not believe they are reflective of our core business and operating results.

    (vi) Deferred compensation. We exclude changes in the fair value of our non-qualified deferred compensation plan because we do not use these to assess the core profitability of our business operations.

    (vii) Income tax effect of non-GAAP pre-tax adjustments. Excluding the income tax effect of non-GAAP pre-tax adjustments from the provision for income taxes assists investors in understanding the tax provision associated with those adjustments and the effect on net income. We utilize an annual non-GAAP tax rate in calculating non-GAAP financial measures to provide better consistency across interim reporting periods by eliminating the effects of certain non-recurring and other period-specific items, which can vary in size and frequency and do not necessarily reflect our normal operations, and to more closely align our tax rate with our expected geographic earnings mix. This annual non-GAAP tax rate is based on an evaluation of our historical and projected mix of U.S. and international profit before tax, taking into account the impact of non-GAAP adjustments, U.S. tax law changes, as well as other factors such as our current tax structure, existing tax positions and expected recurring tax incentives. Based on these considerations, we have elected to adopt a non-GAAP tax rate of 16% for fiscal year 2025.

    INVESTOR CONTACT:

    Trey Campbell

    Synopsys, Inc.

    650-584-4289

    [email protected]

    EDITORIAL CONTACT:

    Cara Walker

    Synopsys, Inc.

    650-584-5000

    [email protected]

    Synopsys (PRNewsfoto/Synopsys)

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/synopsys-posts-financial-results-for-first-quarter-fiscal-year-2025-302386200.html

    SOURCE Synopsys, Inc.

    Get the next $SNPS alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $SNPS

    DatePrice TargetRatingAnalyst
    1/13/2025$600.00Buy
    Redburn Atlantic
    11/22/2024$570.00Equal Weight
    Wells Fargo
    11/12/2024$675.00Buy
    Loop Capital
    10/22/2024$650.00Outperform
    Mizuho
    10/15/2024$660.00Buy
    Berenberg
    4/4/2024$665.00Overweight
    Piper Sandler
    11/30/2023$500.00 → $660.00Buy
    Needham
    11/10/2023$600.00Overweight
    Morgan Stanley
    More analyst ratings

    $SNPS
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Synopsys Announces Earnings Release Date For Second Quarter Fiscal Year 2025

      SUNNYVALE, Calif., May 7, 2025  /PRNewswire/ -- Synopsys, Inc. (NASDAQ:SNPS) today announced it will report results for the second quarter fiscal year 2025 on Wednesday, May 28, 2025, after market close. The company will host a conference call at 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time to review its financial results and business outlook. Financial and other statistical information to be discussed on this conference call will be available on the corporate website at www.investor.synopsys.com immediately before the call. A live webcast will also be available on this sit

      5/7/25 4:05:00 PM ET
      $SNPS
      Computer Software: Prepackaged Software
      Technology
    • Synopsys and Intel Foundry Propel Angstrom-Scale Chip Designs on Intel 18A and Intel 18A-P Technologies

      Synopsys Production-Ready EDA Flows and Broadest IP Portfolio Deliver Leading PPA for Intel Foundry's Advanced Processes and Packaging Technologies Highlights Production-ready Synopsys digital and analog EDA flows for Intel 18A and Intel 18A-P technologies pave the way for broad adoption and accelerate development of high-performance designs; engaged in early design technology co-optimization for Intel 14A-EOptimized EDA reference flow with a unified exploration-to-signoff platform accelerates 2.5D/3D multi-die designs for Intel's EMIB-T advanced packaging technologyBroadest portfolio of high-performance and low-power IP for Intel 18A and expanded Synopsys IP support for Intel 18A-P offers

      4/29/25 12:00:00 PM ET
      $SNPS
      Computer Software: Prepackaged Software
      Technology
    • Synopsys and TSMC Usher In Angstrom-Scale Designs with Certified EDA Flows on Advanced TSMC A16 and N2P Processes

      AI-Driven Digital and Analog Flows, Multi-Die Innovations, and Broad IP Portfolio Deliver Unmatched Performance, Power and Area Advantages Highlights Digital and analog design flows on TSMC A16™ and N2P deliver optimized performance and rapid analog design migration, enabled by Synopsys.aiEarly collaboration on TSMC A14 process underway for Synopsys EDA flows developmentCollaboration on 3Dblox and TSMC's CoWoS® technologies for 5.5x reticle size packages, speeds integration of 3D stacked dies in next-generation AI chipsBroad portfolio of Synopsys Foundation and Interface IP provides the lowest power on TSMC's N2/N2P processesIndustry's most complete IP solutions for leading-edge standards, i

      4/23/25 4:00:00 PM ET
      $SNPS
      Computer Software: Prepackaged Software
      Technology

    $SNPS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by Synopsys Inc. (Amendment)

      SC 13G/A - SYNOPSYS INC (0000883241) (Subject)

      2/14/23 12:37:55 PM ET
      $SNPS
      Computer Software: Prepackaged Software
      Technology
    • SEC Form SC 13G/A filed by Synopsys Inc. (Amendment)

      SC 13G/A - SYNOPSYS INC (0000883241) (Subject)

      2/9/23 11:32:50 AM ET
      $SNPS
      Computer Software: Prepackaged Software
      Technology
    • SEC Form SC 13G/A filed by Synopsys Inc. (Amendment)

      SC 13G/A - SYNOPSYS INC (0000883241) (Subject)

      2/14/22 2:34:19 PM ET
      $SNPS
      Computer Software: Prepackaged Software
      Technology

    $SNPS
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Casper Marc N bought $439,087 worth of shares (750 units at $585.45), increasing direct ownership by 76% to 1,736 units (SEC Form 4)

      4 - SYNOPSYS INC (0000883241) (Issuer)

      3/27/24 11:12:13 AM ET
      $SNPS
      Computer Software: Prepackaged Software
      Technology

    $SNPS
    Financials

    Live finance-specific insights

    See more
    • Synopsys Announces Earnings Release Date For Second Quarter Fiscal Year 2025

      SUNNYVALE, Calif., May 7, 2025  /PRNewswire/ -- Synopsys, Inc. (NASDAQ:SNPS) today announced it will report results for the second quarter fiscal year 2025 on Wednesday, May 28, 2025, after market close. The company will host a conference call at 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time to review its financial results and business outlook. Financial and other statistical information to be discussed on this conference call will be available on the corporate website at www.investor.synopsys.com immediately before the call. A live webcast will also be available on this sit

      5/7/25 4:05:00 PM ET
      $SNPS
      Computer Software: Prepackaged Software
      Technology
    • Synopsys Posts Financial Results for First Quarter Fiscal Year 2025

      Results Summary Quarterly revenue of $1.455 billion, exceeding midpoint of guidance.Quarterly GAAP earnings per diluted share of $1.89; non-GAAP earnings per diluted share of $3.03, exceeding guidance.Reaffirming full-year 2025 guidance.SUNNYVALE, Calif., Feb. 26, 2025 /PRNewswire/ -- Synopsys, Inc. (Nasdaq: SNPS) today reported results for its first quarter of fiscal year 2025. Revenue for the first quarter of fiscal year 2025 was $1.455 billion, compared to $1.511 billion for the first quarter of fiscal year 2024. "In Q1, Synopsys' relentless focus on execution and innovatio

      2/26/25 4:05:00 PM ET
      $SNPS
      Computer Software: Prepackaged Software
      Technology
    • Synopsys Announces Earnings Release Date For First Quarter Fiscal Year 2025

      SUNNYVALE, Calif., Jan. 27, 2025 /PRNewswire/ -- Synopsys, Inc. (NASDAQ:SNPS) today announced it will report results for the first quarter fiscal year 2025 on Wednesday, February 26, 2025, after the market close. The company will host a conference call at 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time to review its financial results and business outlook. Financial and other statistical information to be discussed on this conference call will be available on the corporate website at www.investor.synopsys.com immediately before the call. A live webcast will also be available on

      1/27/25 4:05:00 PM ET
      $SNPS
      Computer Software: Prepackaged Software
      Technology

    $SNPS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Redburn Atlantic initiated coverage on Synopsys with a new price target

      Redburn Atlantic initiated coverage of Synopsys with a rating of Buy and set a new price target of $600.00

      1/13/25 8:42:39 AM ET
      $SNPS
      Computer Software: Prepackaged Software
      Technology
    • Wells Fargo initiated coverage on Synopsys with a new price target

      Wells Fargo initiated coverage of Synopsys with a rating of Equal Weight and set a new price target of $570.00

      11/22/24 8:02:35 AM ET
      $SNPS
      Computer Software: Prepackaged Software
      Technology
    • Loop Capital initiated coverage on Synopsys with a new price target

      Loop Capital initiated coverage of Synopsys with a rating of Buy and set a new price target of $675.00

      11/12/24 7:51:10 AM ET
      $SNPS
      Computer Software: Prepackaged Software
      Technology

    $SNPS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Schwarz John was granted 491 shares, increasing direct ownership by 4% to 12,787 units (SEC Form 4)

      4 - SYNOPSYS INC (0000883241) (Issuer)

      4/14/25 4:22:48 PM ET
      $SNPS
      Computer Software: Prepackaged Software
      Technology
    • Director Sargent Jeannine P was granted 491 shares, increasing direct ownership by 24% to 2,544 units (SEC Form 4)

      4 - SYNOPSYS INC (0000883241) (Issuer)

      4/14/25 4:22:16 PM ET
      $SNPS
      Computer Software: Prepackaged Software
      Technology
    • Director Painter Robert G was granted 491 shares, increasing direct ownership by 34% to 1,941 units (SEC Form 4)

      4 - SYNOPSYS INC (0000883241) (Issuer)

      4/14/25 4:21:38 PM ET
      $SNPS
      Computer Software: Prepackaged Software
      Technology

    $SNPS
    SEC Filings

    See more
    • Synopsys Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Other Events, Financial Statements and Exhibits

      8-K - SYNOPSYS INC (0000883241) (Filer)

      3/17/25 4:30:50 PM ET
      $SNPS
      Computer Software: Prepackaged Software
      Technology
    • Synopsys Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits

      8-K - SYNOPSYS INC (0000883241) (Filer)

      3/5/25 5:18:49 PM ET
      $SNPS
      Computer Software: Prepackaged Software
      Technology
    • SEC Form 424B5 filed by Synopsys Inc.

      424B5 - SYNOPSYS INC (0000883241) (Filer)

      3/5/25 5:17:50 PM ET
      $SNPS
      Computer Software: Prepackaged Software
      Technology

    $SNPS
    Leadership Updates

    Live Leadership Updates

    See more
    • Clearlake and Francisco Partners Complete Acquisition of Black Duck Software, Formerly Known as Synopsys Software Integrity Group

      The standalone application security company continues its mission to help organizations build trust in their software to support innovation and business transformation SANTA MONICA, Calif. and SAN FRANCISCO, Oct. 1, 2024 /PRNewswire/ -- Clearlake Capital Group ("Clearlake") and Francisco Partners announced today that they have completed their acquisition of the Synopsys Software Integrity Group, establishing the newly independent application security company as Black Duck Software, Inc. ("Black Duck"). The transaction with Synopsys, Inc. (NASDAQ:SNPS), which was first announced on May 6, 2024, is valued at up to $2.1 billion, including up to $475 million in cash payable upon Clearlake and Fr

      10/1/24 9:06:00 PM ET
      $SNPS
      Computer Software: Prepackaged Software
      Technology
    • Clearlake and Francisco Partners Complete Acquisition of Black Duck Software, Formerly Known as Synopsys Software Integrity Group

      The standalone application security company continues its mission to help organizations build trust in their software to support innovation and business transformation Clearlake Capital Group ("Clearlake") and Francisco Partners announced today that they have completed their acquisition of the Synopsys Software Integrity Group, establishing the newly independent application security company as Black Duck Software, Inc. ("Black Duck"). The transaction with Synopsys, Inc. (NASDAQ:SNPS), which was first announced on May 6, 2024, is valued at up to $2.1 billion, including up to $475 million in cash payable upon Clearlake and Francisco Partners achieving a specified rate of return in connection

      10/1/24 8:30:00 AM ET
      $SNPS
      Computer Software: Prepackaged Software
      Technology
    • SiMa.ai Secures Funds and Readies New Generative Edge AI Platform

      Oversubscribed $70M round led by Maverick Capital increases SiMa.ai's total amount raised to $270M; funding will speed release of next generation AI/ML chip to power multimodal generative AI at the edge SiMa.ai, the software-centric, embedded edge machine learning system-on-chip company, today announced it has raised an additional $70M of funding led by Maverick Capital, with participation from Point72 and Jericho, as well as existing investors Amplify Partners, Dell Technologies Capital, Lip-Bu Tan and others. SiMa.ai will utilize the $270M raised to date to continue meeting customer demand for edge AI/ML with its first-generation Machine Learning System-on-Chip (MLSoC) while acceleratin

      4/4/24 9:00:00 AM ET
      $SNPS
      Computer Software: Prepackaged Software
      Technology